TOXICITY OF HUMAN RECOMBINANT INTERLEUKIN-2 IN THE MOUSE IS MEDIATED BY INTERLEUKIN-ACTIVATED LYMPHOCYTES - SEPARATION OF EFFICACY AND TOXICITY BY SELECTIVE LYMPHOCYTE SUBSET DEPLETION

被引：0
作者：
ANDERSON, TD
HAYES, TJ
GATELY, MK
BONTEMPO, JM
STERN, LL
TRUITT, GA
机构：
[1] HOFFMANN LA ROCHE INC,DEPT IMMUNOPHARMACOL,NUTLEY,NJ 07110
[2] HOFFMANN LA ROCHE INC,DEPT ONCOL & VIROL,NUTLEY,NJ 07110
来源：
LABORATORY INVESTIGATION | 1988年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：598 / 612
页数：15
相关论文
共 67 条
  • [1] PHASE-I EVALUATION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED MALIGNANT DISEASE
    ATKINS, MB
    GOULD, JA
    ALLEGRETTA, M
    LI, JJ
    DEMPSEY, RA
    RUDDERS, RA
    PARKINSON, DR
    REICHLIN, S
    MIER, JW
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (09) : 1380 - 1391
  • [2] BALLAS ZK, 1987, J IMMUNOL, V138, P1647
  • [3] EFFECTS OF INTERLEUKIN-2 ON RENAL-FUNCTION IN PATIENTS RECEIVING IMMUNOTHERAPY FOR ADVANCED CANCER
    BELLDEGRUN, A
    WEBB, DE
    AUSTIN, HA
    STEINBERG, SM
    WHITE, DE
    LINEHAN, WM
    ROSENBERG, SA
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) : 817 - 822
  • [4] CAVENDER DE, 1986, J IMMUNOL, V136, P203
  • [5] CHANG AE, 1984, J BIOL RESP MODIF, V3, P561
  • [6] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2
    CHEEVER, MA
    GREENBERG, PD
    FEFER, A
    GILLIS, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) : 968 - 980
  • [7] COTRAN RS, 1987, J IMMUNOL, V139, P1883
  • [8] DAMLE NK, 1986, J IMMUNOL, V137, P2814
  • [9] DAMLE NK, 1987, J IMMUNOL, V138, P1779
  • [10] THE NEUROPSYCHIATRIC EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    DENICOFF, KD
    RUBINOW, DR
    PAPA, MZ
    SIMPSON, C
    SEIPP, CA
    LOTZE, MT
    CHANG, AE
    ROSENSTEIN, D
    ROSENBERG, SA
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) : 293 - 300
1234567